LAWSUITS NEWS & LEGAL INFORMATION
Risperdal and risperidone Recalled Legal News Articles & Interviews
January 29, 2017. By Jane Mundy.
Philadelphia, PA: Litigation over the antipsychotic drug Risperdal was the second largest mass tort (just behind Reglan) in 2016 and believed to be mainly responsible for the pharmaceutical inventory in Philadelphia’s Complex Litigation Center to be “at its highest level in recent years.”Read [ Risperdal Litigation Second Largest ]
October 27, 2016. By Gordon Gibb.
Philadelphia, PA: A legal battle currently raging over a statute of limitations for Risperdal lawsuits is being watched closely by plaintiffs facing the potential loss of their Risperdal gynecomastia lawsuit over interpretations as to when plaintiffs could have become aware of a potential association between Risperdal and Growing Male Breasts.Read [ Risperdal Side Effects Lawsuits Hinge on Appeal of Limitations Ruling ]
October 24, 2016. By Jane Mundy.
Minneapolis, MN: Derek has been following the Risperdal lawsuits and subsequent settlements diligently, particularly the recent case that resulted in a $70 million award. Like Adam Yount, Derek'is son has also developed female breast tissue. Unlike Yount, he hasn’t yet been diagnosed with gynecomastia.Read [ Risperdal – The Cost of Teasing and Statute of Limitations ]
September 18, 2016. By Jane Mundy.
Los Angeles, CA: Last month Johnson & Johnson was ordered to pay $18 million because it caused health care providers to submit false claims to Medicare and other federal health care programs. The device in question is a sinus spacer product, but it’s almost a repeat performance of J&J’s Risperdal claims and subsequent settlement.Read [ Johnson & Johnson’s Tale of Two Profit Makers: Risperdal and Relieva ]
September 9, 2016. By Gordon Gibb.
Washington, DC: It’s not that difficult to understand why Johnson & Johnson, the makers of anti-psychotic drug Risperdal (risperidone), would take lawsuits and criticism in stride given the revenues generated by the blockbuster drug: reported by Bloomberg to be $24.2 billion in worldwide sales from 2003 through 2010. In that sense, any corresponding Risperdal lawsuits over Risperdal side effects such as the growth of male breasts, or risk-taking activity beyond the perimeters of regulatory boundaries, could be seen as simply a cost of doing business.Read [ Thousands of Risperdal Lawsuit Allege Risperdal Side Effects ]
August 12, 2016. By Jane Mundy.
Jefferson City, MO: Of all the medications Christopher took for behavioral problems during most of his childhood and early teens, he was prescribed Risperdal for the longest time. As he did in school, “I try to keep my breast problem as secret as I can,” Christopher says.Read [ Young Man Prescribed Risperdal for being a “Little Hellion” ]